: FDA warns that some lots of Tydemy birth control pill may be ineffective


The Food and Drug Administration said Tuesday that two lots of birth-control pill Tydemy, made by privately held Lupin Pharmaceuticals, “may have reduced effectiveness,” which could result in “unexpected pregnancy” due to decreased levels of one of its ingredients, ascorbic acid. The lots affected were distributed in the U.S. between June 3, 2022 to May 31, 2023. The FDA said it had not received any reports of adverse events related to using Tydemy. Lupin issued a voluntary recall and notified consumers on Saturday, the agency said. The company advised patients to continue taking their medication and contact their health care provider for advice about an alternative contraceptive method, the FDA said.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleFutures Movers: Oil prices suffer biggest one-day drop in over a month despite historic fall in crude inventories
Next articleShopify makes progress on free cash flow, but stock moves lower after earnings


Please enter your comment!
Please enter your name here